NEW YORK, July 13 – Bioinformatics company Proteometrics announced Friday that it was restructuring its senior management as it prepares to forge strategic alliances that it hopes will pave the way to strong future growth.
ProteoMetrics of Manhattan, New York, announced that Doug Lockyer had been hired as a co-CEO. Lockyer, who has been a consultant to Proteometrics since 2000, will be in charge of overseeing the company’s business activities.
Lockyer’s main tasks will be to broker strategic alliances and strategic investments and to initiate sales and marketing programs.In a statement, Lockyer said that he expected to make such moves in the near-term.
“Several ‘best of breed’ strategic partners have been identified, and we are in conversation with some firms already about various forms of funding, strategic investment, strategic alliance and development initiative,” Lockyer said.
“The market can look forward to some very bold and visionary initiatives over the next few months, both in alliances announced and marketing campaigns launched. More importantly our customers and partners can look forward to ever-higher levels of service and consolidated software offering which anticipates their bioinformatics needs,” he said.
Lockyer will be based in New York and will also be in charge of building the company’s staff to more than 100 from its current level of 34 employees over the next 18 months. The company is planning to grow its New York office to 60 from 18 as well as hiring in other locations.
Ron Beavis, one of the founders of ProteoMetrics, has been named the CEO of the company’s scientific operations. Beavis was formerly chief scientific officer and president of Proteometrics Canada.
David Fenyo, also a company founder, will take on the roles of president and chief scientific officer. He was previously president and CEO of the company.
Jennifer Krone, formerly vice president of business development and lead solutions architect, has been named vice president of scientific services.